Pharmafile Logo
Pharmafocus logo
Advanced Search

EU

Showing 15 posts of 252 posts found.

Pfizer to consider stockpiling medicines in preperation for no-deal Brexit

August 6, 2018
Sales and Marketing EU, MSD, Pfizer, Sanofi, brexit, stockpiling

Pfizer is considering joining AstraZeneca, Sanofi and MSD in stockpiling medicines in preparation for a hard Brexit, it has emerged. …

News
16193381408_003eb2fdc9_z1

Irish trade lobby warns EU amendments could threaten pharma industry in Ireland, critics contest

August 6, 2018
Sales and Marketing EU, IPHA, Ireland, biosimilars, generics, intellectual property, trade lobby

The Irish Pharmaceutical Healthcare Association (IPHA) has warned that changes to existing intellectual property legislation could threaten innovation and deter …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 3, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, GSK, Sanofi, brexit, pharmafile, top 10

While average temperatures dropped to a comfortable 22 degrees, the past week has put the EMA in a sticky position …

News

Pfizer notches two EU approvals, including Herceptin biosimilar

August 1, 2018
Research and Development, Sales and Marketing Cancer, EMA, EU, Genetech, Herceptin, Pfizer, Trazimera, Xeljanz, biosimilar, breast cancer, pharma

Pfizer is patting itself on the back after securing two new approvals in Europe within 24 hours: Xeljanz (tofacitinib citrate) …

News
kymriah

CHMP recommends Novartis’ CAR-T therapy Kymriah for EU approval

July 5, 2018
Sales and Marketing CAR-T, CHMP, EMA, EU, Kymriah, Novartis, pharma

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Medicines Agency (EMA) approve Novartis’ CAR-T …

News

Pfizer’s Xeljanz scores EU approval for active psoriatic arthritis

June 29, 2018
Medical Communications, Sales and Marketing EU, Europe, Pfizer, Xeljanz, pharma, psoriatic arthritis

Pfizer has announced that the European Commission (EC) has approved Xeljanz in combination with methotrexate (MTX) for the treatment of …

News
gilead-sciences

European Commission greenlights Gilead’s Biktarvy for HIV-1

June 25, 2018
Sales and Marketing Biktarvy, EU, Europe, European Commission, HIV, HIV-1, pharma

Good news for Gilead and HIV patients across the European Union today as the prominent pharma firm announced that its …

News
novartis_outside_1

Novartis’ Sandoz scores EU approval for Remicade biosimilar

May 24, 2018
Sales and Marketing EU, Europe, Novartis, Remicade, Sandoz, Zessly, pharma

The European Commission has given its approval to Sandoz, Novartis’ generics and biosimilars unit, for its biosimilar version of Janssen’s …

News
landing-hero-images1

ViiV’s two-drug regimen gets EU approval for HIV-1

May 22, 2018
Manufacturing and Production, Sales and Marketing EMA, EU, Europe, HIV, Juluca, ViiV Healthcare, pharma

ViiV Healthcare has announced that its HIV therapy Juluca (dolutegravir/rilpivirine) has been awarded marketing authorisation in the EU from the …

News
eu-flag-2108026_960_720

Six reasons why UK pharma has more to gain, than fear, from Brexit

March 26, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, biotech, brexit, drugs, hard Brexit, pharma, pharmaceutical

There are good reasons to think exiting the EU represents a major opportunity for this dynamic and world-leading industry, argues …

Feature
european_commission_web

Takeda and TiGenix’s Alofisel becomes first donor-derived stem cell therapy approved in Europe

March 26, 2018
Sales and Marketing Crohn’s disease, EU, Europe, European Commission, Takeda, TiGenix, crohn's disease, pharma

The European Commission has awarded approval to Takeda and TiGenix’s allogeneic expanded adipose-derived stem cell (eASC) therapy Alofisel (darvadstrocel) for …

News
gsk_boronia_australia

GSK’s shingles vaccine secures EU and Japan approvals

March 26, 2018
Sales and Marketing EU, Europe, GSK, Japan, Shingrix, pharma, shingles

GlaxoSmithKline has announced that its shingles vaccine Shingrix has secured approval in two new regions: in Europe, for the prevention …

News
bayer_cross_2

Bayer-Monsanto deal one step closer, after EU nod

March 22, 2018
Sales and Marketing Bayer, EU, biotech, drugs, monsanto, pharma, pharmaceutical

The merger between Bayer and agricultural giant, Monsanto, is inching closer to completion after the EU Commission won EU antitrust …

News
celltrion1

Celltrion’s Herceptin biosimilar seals EU approval

February 15, 2018
Sales and Marketing EU, Europe, Herceptin, Herzuma, celltrion, pharma

Herzuma, Celltrion’s biosimilar version of Roche/Genentech’s blockbuster immunotherapy Herceptin, has been awarded approval from the European Commission, the company has …

News
lilly_entrance_web

Eli Lilly’s Taltz get EU approval in psoriatic arthritis subgroup

January 24, 2018
Research and Development, Sales and Marketing EU, Eli Lilly, Europe, European Commission, Taltz, pharma, psoriatic arthritis

Eli Lilly has revealed that its IgG4 monoclonal antibody Taltz (ixekizumab) has been awarded marketing approval from the European Commission …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025